2025-12-19 - Analysis Report
Here's a report summarizing the provided information on Rocket Lab USA Inc. (RKLB), followed by a comprehensive analysis:

**Simple Numbers and Analysis**

**1) Return Rate Comparison**

*   **Ticker:** RKLB (Rocket Lab USA Inc.) - A space launch and technology company providing access to space.
*   **RKLB Cumulative Return:** 349.07%
*   **VOO (S&P 500) Cumulative Return:** 48.51%
*   **Divergence:** Current: 266.6 (Relative Divergence: 72.5)

*Analysis:* RKLB has significantly outperformed the S&P 500 over the observed period. The positive divergence suggests RKLB's return has been substantially higher than the market average. The relative divergence of 72.5 indicates that the current divergence is above the historical average compared to the min/max range.

**Alpha, Beta Analysis**

| Year       | CAGR    | MDD     | Alpha   | Beta | Cap(B) |
|------------|---------|---------|---------|------|--------|
| 2020-2022  | -38.0%  | 82.7%   | -18.0%  | 0.1  | 2.0    |
| 2021-2023  | 3.0%    | 82.7%   | 2.0%    | 0.0  | 3.0    |
| 2022-2024  | 210.0%  | 82.7%   | 189.0%  | 0.0  | 13.6   |
| 2023-2025  | 369.0%  | 79.6%   | 305.0%  | -0.0 | 32.0   |

*Analysis:* RKLB's performance varies significantly across different periods.
*   **CAGR:** Fluctuates from negative to very high positive values, demonstrating high growth potential but also substantial risk.
*   **MDD:** High Maximum Drawdown indicates significant volatility.
*   **Alpha:** Predominantly positive, meaning the stock has generally outperformed its benchmark after adjusting for risk.
*   **Beta:** Close to zero, indicating low systematic risk, i.e., the stock's price is not highly correlated with overall market movements.
*   **Cap(B):** Market capitalization has increased significantly over time, reflecting growth in the company's perceived value.

**2) Recent Stock Price Fluctuations**

*   **Close:** 59.92
*   **Previous Close:** 53.96
*   **Change:** 11.05
*   **5-day SMA:** 57.254
*   **20-day SMA:** 49.4013
*   **60-day SMA:** 54.6346

*Analysis:* The stock price has recently increased significantly, as indicated by the large positive change. The 5-day SMA is above the 20-day and 60-day SMAs, suggesting an upward trend.

**3) Indicators**

*   **Market Risk Indicator (MRI):** 0.7 (Medium Investment Recommended)
*   **RSI:** 73.42 (Overbought territory)
*   **PPO:** 2.72 (Positive, indicating an upward trend)
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (4 shares - Safe - MRI:0.80)
*   **Recent (20 days) relative divergence change:** 3.8 (+): 단기상승 (Short-term rise)
*   **Expected Return (%):** 9.1%

*Analysis:*

*   **MRI:** Suggests a medium level of risk and a moderate recommendation for investment.
*   **RSI:** Indicates the stock may be overbought and prone to a correction.
*   **PPO:** Confirms an upward trend in price momentum.
*   **Hybrid Signal:** Recommends buying a significant portion of shares with a 'safe' rating.
*   **Divergence Change:** Reinforces the short-term upward trend.
*   **Expected Return:** Indicates potentially strong future returns, but this is based on a long-term investment horizon.
*   **Large price change:** should be interpreted with caution, as it might signal a sharp rebound or decline.

**4) Recent News & Significant Events**

*   **Positive News:** News articles highlight a recent price surge ("Why Is Rocket Lab (RKLB) Stock Soaring Today").
*   **Mixed News:** Other articles mention insider selling ("Rocket Lab (RKLB) Stock After Hours: Insider Selling Weighs on Shares as U.S. Space Force Launch Looms Ahead of the Dec. 18 Market Open").
*   **Industry News:** Mentions of SpaceX and the space stock industry ("SpaceX IPO: What I Learned From Rocket Lab").

*Analysis:* The news is mixed. Positive articles contribute to investor sentiment. Negative articles about insider selling may cause concern. The industry overview may impact the valuation.

**4-2) Analyst Opinions**

*   **Target Price (avg/high/low):** 65.67 / 83.00 / 47.00

*Analysis:* The average target price suggests a potential upside from the current price, but the wide range reflects uncertainty among analysts.

**5) Recent Earnings Analysis**

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-11-10 | -0.03 | 0.16 B$  |
| 2025-08-07 | -0.13 | 0.14 B$  |
| 2025-05-08 | -0.12 | 0.12 B$  |
| 2024-11-12 | -0.10 | 0.10 B$  |
| 2025-11-10 | -0.10 | 0.10 B$ |

*Analysis:* Rocket Lab is currently not profitable (negative EPS). Revenue is increasing, but losses persist. The most recent EPS shows significant improvement compared to previous figures.

**6) Financial Information**

**Revenue and Profitability**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-09-30   | $0.16B  | 36.96%        |
| 2025-06-30   | $0.14B  | 32.10%        |
| 2025-03-31   | $0.12B  | 28.76%        |
| 2024-12-31   | $0.13B  | 27.81%        |
| 2024-09-30   | $0.10B  | 26.71%        |

**Capital and Profitability**

| Quarter      | Equity  | ROE       |
|--------------|---------|-----------|
| 2025-09-30   | $1.28B  | -1.43%    |
| 2025-06-30   | $0.69B  | -9.65%    |
| 2025-03-31   | $0.43B  | -14.05%   |
| 2024-12-31   | $0.38B  | -13.69%   |
| 2024-09-30   | $0.42B  | -12.37%   |

*Analysis:*

*   **Revenue:** Revenue is consistently increasing, indicating strong growth in the company's sales.
*   **Profit Margin:** Profit margin is also increasing, suggesting improved operational efficiency, but still below positive number.
*   **Equity:** Equity has increased significantly, particularly in the most recent quarter, likely due to stock offerings or other capital raising activities.
*   **ROE:** Negative Return on Equity indicates that the company is not generating profit from its equity investments. However, ROE is improving, aligning with revenue and profit margin growth.

**7) Comprehensive Analysis**

Rocket Lab (RKLB) presents a mixed picture. The company has shown tremendous growth potential as evidenced by its impressive cumulative return and CAGR figures. However, this growth comes with significant volatility (high MDD). While Alpha is consistently positive, Beta remains low, indicating that the stock's performance is largely independent of broader market movements.

Financially, RKLB is still in a growth phase. Revenue is increasing consistently, as is the profit margin (though still not positive), and most recent EPS shows signs of substantial improvement. This revenue growth and recent EPS signals suggests the company is moving toward profitability. Analyst target prices generally suggest potential upside.

The MRI indicates a medium level of risk, and the hybrid signal leans towards a "buy" recommendation. However, the RSI indicates an overbought condition, and investors should be aware of potential short-term corrections. Recent positive news may be contributing to the upward trend, but negative news about insider selling should be monitored.

**In Summary:** RKLB is a high-growth, high-risk investment. It has significant potential for future returns, but investors should be prepared for volatility and the fact that the company is not yet consistently profitable. Continuous monitoring of financial performance, industry news, and market indicators is crucial.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.